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Matkapuhelinten ja erityisesti niiden radiotaajuuksisen sähkömagneettisen säteilyn 
terveyshaittoja on tutkittu laajalti sekä kokeellisesti että väestötasolla. Tutkimuksissa on 
kuitenkin paljon puutteita ja toistettavaa osoitusta haitallisista terveysvaikutuksista ei ole saatu. 
Tämän tutkimuksen tavoite oli selvittää laajan matkapuhelimen käyttäjien seurantatutkimuksen 
kansanterveydellisiä sekoittavia tekijöitä eri puheluaikaryhmissä. 
 
Tutkittavat (8 104) olivat TeliaSoneran ja Elisan yksityisasiakkaita iän ja sukupuolen mukaan 
ositetusta otannasta seurantatutkimuksen lähtötilanteesta. Heidät jaettiin altistusryhmiin (alle 
50%, 50–74%, 75–89% ja yli 90%) operaattoreilta saadun puheajan mukaan ja tiedot 
aiemmista diagnooseista, lääkityksestä, elintavoista ja sosioekonomisesta asemasta saatiin 
kyselylomakkeesta. 
Korkeimman desiilin puheaikaryhmällä oli selvästi suurentunut riski sepelvaltimotautiin (OR 
1.79, CI 1.17–2.75), astmaan (OR 1.70, CI 1.15–2.52), masennukseen (OR 1.43, CI 1.16–1.76) 
ja verenpainetautiin (OR 1.31, CI 1.09–1.58). Samanlaiset tulokset saatiin myös 
verenpainelääkkeistä ja masennuslääkkeistä. Syövän, tyypin 2 diabeteksen ja kohonneen 
kolesterolin vallitsevuus kasvoi puheajan kasvaessa, mutta ei tilastollisesti merkitsevästi. 
Merkittäviä eroja ei löytynyt keuhkoahtaumataudin vallitsevuudessa. Ylipaino (OR 1.72, CI 
1.49–1.99), tupakointi (OR 1.39, CI 1.19–1.63) ja päivittäinen fyysinen aktiivisuus (OR 1.18, 
CI 1.01–1.39) olivat yleisempiä suuremman puheajan ryhmällä. Alkoholin käytöllä ei ollut 
yhteyttä puheaikaan. Paljon puhelimessa puhuvat olivat vähemmän koulutettuja (OR 0.73, CI 
0.63–0.85), useammin yrittäjiä (OR 3.06, CI 2.13–4.40) ja harvemmin parisuhteessa (OR 0.57, 
CI 0.48–0.68) kuin vähän puhuvat. Kun altiste painotettiin matkapuhelinverkon (2G/3G) 
mukaan, erot altistusryhmien välillä sairauksissa, lääkityksissä ja elämäntavoissa kapenivat, 
mutta erot sosioekonomisessa asemassa olivat samankaltaisia kuin alkuperäisessä analyysissä. 
Kansantaudit ja terveyden riskitekijät olivat yleisempiä niillä ryhmillä, joilla oli suurimmat 
puheajat. Tämän tutkimuksen perusteella tulevissa matkapuhelintutkimuksissa on kiinnitettävä 
erityistä huomiota sekoittavien tekijöiden tarkasteluun tai ne ovat aiheuttamassa harhaa. 
 
Avainsanat: matkapuhelimen käyttö, poikkileikkaustutkimukset, radioaallot, tartuntatauteihin 
kuulumattomat taudit, terveyskäyttäytyminen 
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1 INTRODUCTION 
 
 
 
The possibility that exposure to radiofrequency electromagnetic fields (RF-EMF, 30 kHz–300 
GHz) from mobile phones and other wireless devices might increase risk of adverse health 
outcomes has sustained an interest in both public audience and scientific community. Natural 
RF-EMF arises mainly from black-body radiation of lightning discharges and terrestrial 
objects.  Modern people are exposed to RF-EMF to a greater extent than ever before, since the 
most significant sources are man-made: radio and television broadcasting, radars, industrial 
appliances such as heat-sealers, medical devices such as MRI imaging, Wi-fi devices and 
mobile phone base stations. However, mobile phones are the most important source of exposure 
to RF-EMF in everyday life. (1-3) The expansion of mobile technology has been rapid during 
the last decades. For example, in the EU there were approximately 1370 mobile phone 
subscriptions per 1000 inhabitants in 2016 (4). According to a forecast, there will be over 9 
billion mobile phone subscriptions globally in 2020. (5) Finland has been one of the leading 
countries in mobile phone use since the 1990s, and in 2018 there were almost 6,9 million 
mobile subscriptions in the Finnish households alone. (6) 
The health effects of RF-EMF have been studied for over two decades, motivated more by a 
public apprehension rather than any specific hypothesis founded on a biophysically plausible 
mechanism or epidemiologically proven causality. The main interests of previous studies have 
been biophysical effects of RF-EMF on risk of tumours, especially intracranial and 
haematological neoplasms. The results are predominantly negative, and reliable, repeatable 
evidence of adverse health effects at the exposure levels encountered in the general population 
have not been reported by several expert groups. (1-3) However, some diverging results and a 
broad range of methodological problems keep the scientific community from drawing final 
conclusions. Recently, psychosocial effects of RF-EMF devices has been an emerging field of 
research, in addition to the research based on the biophysical effects. (7-11) 
In 2015 a scientific committee founded by the European Commission  (SCENIHR) presented 
a risk assessment concluding from three independent lines of evidence (in vitro studies, in vivo 
animal studies and epidemiological studies) that exposure to RF-EMF below exposure limits 
defined in guidelines is unlikely to lead to an increase in cancer or other diseases (3). 
4 
 
Nevertheless, the World Health Organization’s International Agency for Research on Cancer 
(IARC) has classified RF-EMF “Possibly carcinogenic to humans” (group 2B). This category 
is used for agents for which there is “limited evidence” of carcinogenicity in humans and “less 
than sufficient evidence” of carcinogenicity in experimental animals. IARC concluded that 
there is limited evidence in both humans and experimental animals for the carcinogenicity of 
RF-EMF. The epidemiological evidence was rated as mixed, but associations between acoustic 
neuroma or glioma and mobile phone use were considered more than inadequate. (2)  
RF-EMF is non-ionizing radiation i.e. it does not carry enough energy to directly break 
chemical bonds or ionize molecules. According to the current knowledge, tissue heating is the 
best-established effect on living organisms from exposure to RF-EMF at levels encountered in 
everyday environment. In addition, a few non-thermal mechanisms have been suggested, 
including magnetic field effect on radical pair recombination rates, ferrimagnetic or molecular 
resonances, effects on ion flux, and oxidative stress. (12,13) However, it has been argued that 
the tissue heating mechanism would surpass the other possible mechanisms, because the 
temperature rise needs to be high the other mechanisms to have an effect on the tissues. The 
public exposures guidelines for RF-EMF are set to avoid excessive heating of tissues by 
limiting exposures to remain sufficiently low. (1-3) To conclude, no biological mechanism has 
been identified that could explain adverse health effects.  
Most of the in vitro and in vivo -studies have not found any biological changes as a result of 
exposure to RF-EMF, and the few positive results have not been repeatable. (1-3) However, a 
few recent studies have established a statistically significant increase in the incidence of 
schwannomas of the heart in RF-EMF exposed Sprague-Dawley male rats. It is noteworthy 
that these findings are somewhat consistent with some epidemiological studies of mobile phone 
users, with some evidence of a connection of tumours of the same cytological origin, namely 
vestibular schwannoma also known as acoustic neuroma, and mobile phone use. (14-16) These 
new results complicate the question of RF-EMF and health further. 
Short term provocation studies with double-blind exposure and sham exposure setup have not 
shown evidence of symptoms or physiological effects triggered by RF-EMF exposure. Some 
people react to both sham and real exposure, when they think they are under an influence of 
real exposure, and on the other hand their symptoms are missing when there is a real exposure 
that they are not aware of. (17,18) This suggests that there is a nocebo mechanism 
accompanying RF-EMF exposure. Nocebo is a widely known phenomenon in medicine in 
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which a treatment produces nonspecific adverse side effects which are not a direct result of the 
biological actions of the treatment. Factors suggested to affect nocebo are patient’s 
expectations of adverse effects of the treatment and prior experiences, psychological 
characteristics of the patient, and situational factors. (19) Furthermore, there is no evidence that 
people who report being hypersensitive to RF-EMF have unusual physiological reactions from 
RF-EMF or that they could reliably detect whether they are under the influence of RF-EMF. 
(17,20,21) The results of the short-term provocation studies do not, however, eliminate the 
possibility of long-term effects on health of repeated exposure to mobile phones. 
According to ecological and simulation studies, there has been no increase in brain tumour 
incidence during the period when the popularity of mobile technology has expanded. In a study 
of the US population in 1992–2008, brain tumour incidence remained generally unchanged 
while mobile phone use increased from close to 0 % to almost 100 %. (22) Similar results were 
observed in studies of the English population from 1998 to 2007, in Sweden during 1980–2012, 
and in Taiwanese in 2000–2009. (23-25) In a Nordic study of glioma incidence in 1978–2008 
and simulation of expected incidence growth, no trend change in glioma incidence was found. 
Furthermore, the simulation showed inconsistency with the results of case-control studies and 
stable incidence of gliomas for latency period up to 10–15 years. (26) The latest study of 
Finnish population from 1990–2016 showed no increasing incidence trend of malignant 
gliomas, except a slight increase in the age group of 80 and older during 1990–2006. (27) 
However, the induction time of tumours affected by RF-EMF might exceed 20 years, and in 
that case, we might not observe increases in those conditions yet. In addition, there could be 
another environmental factor causing tumours to decrease at the same time mobile phones are 
increasing the occurrence of cancers and other tumours. The latter being an improbable 
scenario, it is important to focus on studies with sufficient follow-up time. 
In a 2008 cross-sectional study with personal dosimetry exposure assessment, no statistically 
significant associations between the exposure and chronic or acute symptoms were found. The 
symptoms studied were headache, neurological symptoms such as tinnitus, numbing in limbs, 
eyelid twitch, cardiovascular symptoms, sleeping disorders, fatigue and concentration 
problems. (28)  
To date, the largest epidemiological study on intracranial tumours and mobile phones is the 
Interphone study. It was a case-control study on RF-EMF exposure from mobile phones in 13 
countries. (29) A correlation was found between gliomas and acoustic neuromas in the highest 
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decile of mobile phone usage with a cumulative call-time of ≥1640 hours, but otherwise there 
was no exposure-gradient. (30,31) The exposure assessment was based on a self-reported 
mobile phone use. In a Korean case-control study with methods based on the Interphone, there 
was a non-significant increase in glioma risk among ipsilateral users, whose body side for usual 
mobile phone use matched the location of glioma, and a decrease in contralateral users. (32)  
Besides the Interphone study, several other case-control studies have been conducted on mobile 
phone and health effects, mainly tumours. In a Swedish case-control study long-term mobile 
phone use did not increase risk of acoustic neuroma, but there was a bias observed when taking 
into account the whole history of laterality of the subject’s mobile phone use. The cases 
reported changes of their preferred side more often than the controls, and consequently strongly 
reduced risk estimates for ipsilateral use and increased risk estimates for contralateral use were 
obtained. (33) Pooled analyses of two other Swedish case-control studies from 1997–2003 and 
2007–2009 showed an increased risk for glioma associated with cumulative and ipsilateral use 
of mobile phones and for meningioma associated with heavy mobile phone use. (34,35) A 
French case-control study found no association of brain tumours when comparing regular 
mobile phone users to non-users, but a statistically significant positive association was found 
for gliomas and meningiomas in the heaviest users of mobile phones. (36) For pituitary 
tumours, no evidence of increased risk with mobile phone use were found in two separate case-
control studies in Finnish and English populations. (37,38) In a Swedish study, no support for 
an increased risk for parotid gland tumours associated with mobile phone use was found. A 
case-control study has been conducted as well on leukaemia and mobile phone use, where no 
association was found. (39) All of these studies based their exposure assessment on interviews 
or questionnaires.  
In a large Danish cohort study of mobile phone subscribers, evidence has been found for a 
weak connection of migraine and vertigo with mobile phone exposure. No evidence of an 
increased risk of cancer, or amyotrophic lateral sclerosis was shown, but decreased risks of 
epilepsy, dementia and Parkinson’s disease were found among male subscribers. Results of 
multiple sclerosis was mixed. Among female subscribers, an increased long-term risk of 
multiple sclerosis was observed, but the finding was based on very few cases. However, the 
studies of the Danish cohort had no other information on the amount of mobile phone use than 
the years of subscription. (40-43) Another large prospective cohort study, the British Million 
Women Study, reported a relation between acoustic neuroma and the use of mobile phone, but 
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mobile phone use was not associated with incidences of other intracranial tumours. However, 
with further follow-up data, there was no longer association with acoustic neuroma found. 
Besides tumours, the Million Women Study examined associations between cardiovascular 
diseases and mobile phone use. Daily use of a mobile phone was associated with higher risk of 
angina pectoris and ever use of mobile phone was associated with reduced risk of stroke. 
(44,45) 
The latest meta-analysis by Röösli et al. (46) summarizes the epidemiological evidence of 
cancer risk and RF-EMF. In short, epidemiological studies do not confirm a connection 
between increased intracranial tumour risk and mobile phone use, but the evidence is mixed 
with long latency periods (>15 years) and the rarest subtypes of brain tumours, for which 
epidemiological studies are difficult to conduct due to extremely low numbers of cases. 
The methodological limitations of previous studies on mobile phones and health are numerous. 
First, previous epidemiological studies, not to mention experimental provocation studies, are 
not informative on long term effects, regarding cancers with long latency periods. Second, in 
the epidemiological studies, the measurement of the exposure has not been exact. There must 
be a possibility for exposure gradient analysis because in the modern world the RF-EMF 
exposure cannot be on/off. The third problem has to do with the case-control design, which has 
been used in most of the epidemiological studies. In case-control studies based on self-report, 
there is the possibility of information bias, when the cases might overreport their mobile phone 
usage and the controls underreport. Furthermore, the response proportions among control 
groups have been low, which may lead to selection bias. (47-51) Fourth, case-control studies 
lack the opportunity to assess a large number of outcomes. RF-EMF studies on diseases have 
concentrated mainly on intracranial tumours and neurological diseases, and little attention has 
been given to more common non-communicable diseases (NCD), which include heart disease, 
cancer, diabetes and chronic lung disease. (52) Although RF-EMF from mobile phones is so 
called near-field exposure and most of the radiation energy is absorbed in one side of the head 
during calls, the exposure affects also to the whole body and other organs than brain which can 
mediate a variety of outcomes. (53) To conclude, a broad prospective cohort study with an 
extensive follow-up period and a broad variety of outcomes was needed to clarify the evidence 
of mobile phones and adverse health effects. 
There is one additional question concerning mobile phone use and health. If a connection 
between adverse health effects and mobile phone use exists, does it necessarily arise from the 
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RF-EMF exposure? There has been an increasing interest in the psychological and behavioural 
perspective of mobile phone use, especially since smartphones became increasingly common. 
In this field of research, the adverse health effects of mobile phone use are not so much 
hypothesised to be caused by RF-EMF as psychosocial stress or tendency to addictive 
behaviour. The direction of causation is difficult to evaluate. Nevertheless, mobile phone use 
has been associated with stress, anxiety, adolescent behavioural problems, depression, sleep 
disorders, alexithymia and “the fear of missing out”. (7-11)  
Considering the difficulty to evaluate the causal relationships, there is a significant lack of 
research which studies the question of which kinds of people use mobile more than the average. 
This is important in evaluating the potential confounding factors of mobile phone and health 
studies, regardless of the assumed causal mechanism. 
The Cohort Study on Mobile Phones and Health (Cosmos) was established to answer the 
methodological problems of previous studies mentioned. Cosmos is an international 
prospective study from mobile phone use and diverse adverse health outcomes with over 
280,000 participants recruited during 2008–2011 in Sweden, Finland, Denmark, the United 
Kingdom and the Netherlands. The latest country to join the project was France. Exposure data 
is collected from operator databases and outcomes are assessed by repeated self-report 
questionnaires or data through national health registries. The participants, aged 18+ years, will 
be followed up for 25+ years. Due to the cohort approach, several types of health outcomes can 
be assessed, from cancer to psychosocial disorders. Findings from the first Finnish and Swedish 
repeated questionnaires and data have already been published. (54)  
In this study, the aim is to report a cross-sectional study of the connection between mobile 
phone use and NCD and the main risk factors of these diseases. The findings are based on the 
Finnish Cosmos data. This study does not examine a causal relationship between mobile phone 
use and adverse health outcomes, but it will provide a background for the future prospective 
cohort studies and help to control the potential confounding factors, plan the analysis and 
interpret the results.  
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2 METHODS  
 
 
 
2.1 Study population 
 
The study subjects were identified from the subscriber databases of mobile phone network 
operators TeliaSonera (currently known as Telia Finland) and Elisa in Finland. Letters of 
invitation, forms of informed consent and questionnaires were mailed to stratified random 
samples of mobile phone subscribers. Stratified sampling by age, amount of mobile phone use 
and gender was employed with the intention to balance exposure-age distributions within the 
cohort to maximise statistical power. Corporate subscriptions were excluded due to difficulties 
in obtaining a valid consent for the data. A detailed description of the cohort recruitment has 
been published previously. (55) In this study, the operator data was obtained from the year of 
the subject’s consent and disease history variables used in the analysis were acquired from the 
baseline questionnaire. The baseline questionnaire covered information about exposure history, 
the overall state of health, diseases, medications, alcohol use, smoking, height, weight and 
socio-demographic factors. The questionnaire was available as both paper and electronic 
versions.  
In total 15,477 subjects (9.4% of all invited) gave consent to the study. Complete baseline 
mobile phone data was obtained for 9,085 participants (6.0%) for whom the operator data was 
successfully linked on mobile phones they used at the baseline. Exclusion criteria for this study 
were: 1) lack of informed consent or baseline questionnaire, 2) no mobile phones reported or 
more than two mobile phones reported, 3) lack of comprehensive call data of any mobile 
phones reported), 4) missing data on the use of a hands-free device in the questionnaire, and 5) 
indication of other people using any of the reported mobile phones “often” in the baseline 
questionnaire. The participants aged 70 or older were excluded as well, leaving 8,104 eligible 
subjects (5.4%) to the analysis. (Figure 1) 
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Figure 1 Flowchart of the study subjects 
 
2.2 Exposure assessment 
 
The indicators of the exposure to RF-EMF from a mobile phone are the number of calls and 
the duration of calls (56), and these factors are covered by the operator data used in the analysis. 
The mobile phone data used in this study included the cumulative call-time from a period of 3 
months and the type of the network used (2G/3G/unknown). The main exposure in this study 
was each individual’s mean weekly call-time calculated from the cumulative call-time of 
individual calls. The exposure groups were categorized by the weekly usage of mobile phone: 
0-49%, 50-74%, 75-89%, and 90-100%.  Mean weekly use was adjusted for the reported use 
of a hands-free device. For “Less than half the time”, “About half the time”, “More than half 
the time” and “Always/almost always” exposure was reduced to 95%, 90%, 75%, and 50% of 
the original value, based on data from a study by Goedhart et al. (57) (Table 1) 
164,081 subjects 
invited
15,477 gave consent
13,062 filled in baseline 
questionnaire
9,085 had operator 
data on all reported 
mobile phones 
8,663 answered to the 
question on hands-free
use
8,119 answer to "how 
often do other people 
use reported phones" 
was not "often"  
8,104 included, aged 
18–69 
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Table 1 Adjustment of the operator exposure to the reported use of hands-free devices 
Over the last 3 months, how often have you used a hands-free 
device when making or receiving calls? 
Adjusted 
exposure 
Never/almost never X 
Less than half the time 0.95×X 
About half the time 0.90×X 
More than half the time 0.75×X 
Always/almost always  0.50×X 
 
Additional analyses were conducted for call-time adjusted by the network used and for call-
time with the hands-free coefficient removed. In the network analysis, the call-time in 2G 
(GSM) and unknown networks remained the same, but call-time in 3G (UMTS) network was 
divided by 150 based on the lower output power of the third generation network. (58)  
 
2.3 Health outcomes 
 
Of the previous diagnoses, asthma, angina pectoris or myocardial infarction (MI), any cancer, 
chronic obstructive pulmonary disease (COPD), depression, type 2 diabetes (DM2), arterial 
hypertension (HA), and hypercholesterolemia were included. Medications for hypertension, 
hypercholesterolemia, diabetes (pills and insulin) as well as depression were included. For 
these outcome variables, the baseline questionnaire was used. Risk factors taken into account 
were age, gender, weight, height, alcohol, smoking, physical activity, education, occupation, 
employment status and relationship status. In addition, summary scores from the SF-12 Health 
Survey were analysed.  
Categorical or continuous variables were derived from the answers to the questionnaire. 
Diagnoses and medications were treated as binary variables. From the SF-12 Health Survey, 
physical and mental health composite scores were calculated and these remained as continuous 
values (59). Alcohol intake was defined as the total number of units per week based on the 
question “How much of each of the following types of alcohol did you drink in a typical week 
during the last year?”  and was then categorized according to the Finnish risk drinking 
guidelines into risk users and others, with a cut-point 24 alcohol units per week for men and 
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16 for women. (60) Smoking was defined as a cumulative consumption (pack-years) assigned 
from the questionnaire responses and was categorised into non-smokers, <10 packyears, 10-20 
pack-years and 20 pack-years or more. Additionally, subjects were grouped into non-smokers, 
ex-smokers and current smokers. Physical activity included both work-related and leisure-time 
physical activity. Values were categorized as active (daily leisure-time heavy/lighter physical 
activity or heavy activity daily at work) and not active (others). Height and current weight from 
the questionnaire were used to calculate the Body Mass Index and grouped into normal or 
underweight (<25 kg/m2), overweight (25–29 kg/m2), or obese (30+kg/m2). Age groups were 
under 30 years, 30–39 years, 40–49 years, 50–59 years, and 60–69 years. 
Employment status was defined as currently employed “yes” or “no”. “No” covered everyone 
who was not active (unemployed, sick leave, retired). Relationship status was defined as having 
a relationship (married, cohabiting, or other) “yes” or “no”. Educational level was defined in 
three categories: “basic” (“compulsory school” or “other”), “secondary” (“upper secondary 
school”, “vocational training”), and “university” (“college”, “university”). The occupation was 
defined as “labourer”, “clerical”, “managerial”, “entrepreneur”, and “other/outside work”. 
For data cleaning, range checks for numerical values (height and weight, cigarettes, alcohol 
use) were used to exclude implausible values.  
 
2.4 Statistical analysis and ethical permission 
 
Each outcome category was assigned the stratum-specific mean amount of use per week based 
on operator data. Logistic regression was used for binary outcomes, multinominal or ordinal 
logistic regression for polytomous outcome variables, and category-specific medians were 
sought for continuous variables. All analyses were adjusted for age and gender. Odds ratios 
(OR) were calculated with the participants in the lowest exposure category as the reference and 
random variation was estimated through 95% confidence intervals (CI).  In addition, trend tests 
were used with the indicator for exposure category as a continuous variable for evaluating an 
exposure gradient effect. The cut-off p<0.05 was considered as a statistically significant result. 
Dropout analysis was performed for the excluded data to assess possible selection effect. Cross-
tabulations and chi-squared tests were used for the dropout analysis. The analyses were 
conducted with Stata 13.1. 
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The study protocol of Cosmos was reviewed by The Regional Ethics Committee of Tampere 
University Hospital, Pirkanmaa Hospital District, with tracking numbers R04179 and R09105.  
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3 RESULTS 
 
 
 
The median age of the participants was 52.5 years, and the median age of the different call-
time groups did not vary significantly. Proportions of age categories in the call-time groups are 
presented in Table 2. In total 4,773 (58.9%) of the participants were women, and the percentage 
of women ranged from 53.1% to 65.7% across the exposure categories. (Table 2) The median 
call-time of men was 82 minutes and women 108 minutes.  
In the dropout analysis, participants did not differ from the excluded subjects in age, gender, 
diagnosis, medications, or lifestyle habits. In the excluded group there were more university 
degrees (62.2% vs 53.7%, p<0.00) and managerial occupations (31.4% vs 20.8%, p<0.00) and 
less employment (29.1% vs. 42.9%, p<0.00).  
The amount of weekly call-time was highly skewed toward low values with a maximum of 
2177 minutes and over 98% of participants had call-time under 500 minutes. (Figure 2) Call-
time in minutes for different exposure categories is presented in Table 2. 
 
 
Figure 2 Distribution of weekly mean call-time (min) among participants with <500 min/week (7994 participants, 
98.6%) 
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Table 2 Call-time minutes, age and gender in exposure categories 
 
 
Previously diagnosed angina pectoris, asthma, cancer, depression, DM2, hypertension, and 
hypercholesterolemia were more common among the participants in the highest call-time 
categories. (Table 3) In addition, overweight, daily physical activity and current smoking were 
more frequent among heavy mobile phone users. Compared with the group with the lowest 
50% weekly call-time the participants with higher amount of call-time were more often 
entrepreneurs, less often employed, less educated and less often in a relationship.  (Table 4) 
The 10% of participants with the largest amount of call-time had an increased adjusted OR of 
previous diagnosis of angina pectoris or MI (OR 1.79, CI 1.17–2.75), asthma (OR 1.70, CI 
1.15–2.52), depression (OR 1.43, CI 1.16–1.76) and depression medication (OR 1.68, CI 1.30–
2.17), as well as arterial hypertension (OR 1.31, CI 1.09–1.58) and HA medication (OR 1.29, 
CI 1.06–1.57). For asthma, also the 50–74th percentile and the 75–89th percentile had increased 
OR (OR 1.48, CI 1.09–2.00; OR 1.85, CI 1.33–2.58) and there was an increase of OR across 
the call-time categories (p trend 0.00). In addition, angina pectoris or MI (p trend 0.01), 
depression (p trend 0.00), and depression medication (p trend 0.00), showed gradient by call-
time. No statistically significant results were obtained for cancer, COPD, DM2, 
hypercholesterolemia, or medication for DM2 or hypercholesterolemia, but for all of these 
diseases, excluding COPD, OR was increased in the 90–100th percentile group. (Table 5) 
Overweight increased across call-time categories with OR from 1 to 1.72 (p trend 0.00). 
Similarly, OR of current/ex smoking increased from 1 to 1.39 (p trend 0.00). For smoking 
categorised as packyears, the 50–74th percentile and 90–100th percentile groups had statistically 
significantly increased OR of higher amount of packyears (OR 1.16, CI 1.03–1.31; OR 1.31, 
CI 1.11–1.55, p trend 0.00). The 75–89th percentile and 90–100th percentile groups had 
increased OR of physical activity (OR 1.20, CI 1.05–1.38; 1.18, CI 1.01–1.39, p trend 0.01). 
For risk drinking, there was no statistically significant difference between groups. (Table 6)  
Call-time 
category 
Minutes 
(mean) 
Age (years, 
median) 
Age categories (%) Females 
(%) 
   18–30 30–39 40–49 50–59 60–69  
Lowest 49% 
 
≤97.5 52.2 16.0 15.3 14.8 20.3 33.7 53.1 
50–74th 
percentile 
97.5–174 52.6 11.7 17.3 14.9 22.1 34.1 65.7 
75–89th 
percentile 
174–264.1 53.2 9.9 16.0 17.5 20.6 36.1 64.4 
90–100th 
percentile 
>264.1 52.2 10.5 14.4 19.6 24.5 31.0 62.4 
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In the analysis of socio-demographic factors, several associations were found between call-
time groups compared with the lowest 50% weekly call-time. Employment decreased across 
call-time categories with OR from 0.85 to 0.60 (p trend 0.00) and, on the contrary, being an 
entrepreneur increased strongly by the amount of mobile phone use with OR from 1.83 to 3.06 
(p trend 0.00). The 10 % of the participants with the largest amount of weekly call-time had 
lower level of education (secondary education OR 0.77, CI 0.61–0.97 and university OR 0.65, 
CI 0.52–0.79) and were less often in a relationship (OR 0.57, CI 0.48–0.68). In addition, the 
findings were similar in the 75–89th percentile group. University education and relationship 
status showed statistically significant gradient by call-time. (Table 6) No considerable 
differences were observed in SF-12 composite scores between exposure groups. (Figure 3 and 
4) 
In the analysis of call-time by network type (2G/3G), results with asthma and socio-
demographic factors remained largely similar. For angina pectoris, depression, hypertension 
and medications for these conditions, OR was increased in the highest call-time category, but 
there were no statistically significant differences between call-time groups, in contrast to the 
original analysis. For physical activity, the 75–89th percentile and 90–100th percentile groups 
had increased OR (OR 1.28, CI 1.12–1.47; 1.32, CI 1.13–1.55, p trend 0.00), thus stronger 
trend across the categories was observed compared to the main analysis. For smoking the 
network analysis showed no substantial differences between groups. Overweight was more 
common among the 10% of the participants with the largest amount of weekly call-time (OR 
1.46, CI 1.26–1.68). The 50–74th percentile group had a decreased OR of previous cancer (OR 
0.77, CI 0.61–0.98) compared with the group with the lowest 50% call-time. (Table 7 and 8) 
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Table 3 Prevalence for diagnoses and medications by amount of mobile phone use 
 Prevalence, % (N)  
 Lowest 
49% 
50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
Total Participants1, 
N 
Angina pectoris/MI 2.8 (111) 3.2 (64) 3.2 (38) 3.8 (30) 3.1 (243) 7,930 
Asthma 2.5 (102) 3.8 (77) 4.7 (57) 4.3 (35) 3.4 (271) 8,047 
Cancer 5.5 (220) 6.3 (127) 6.3 (76) 7.0 (56) 6.0 (479) 8,045 
COPD 1.1 (42) 1.4 (27) 1.3 (16) 0.9 (7) 1.2 (92) 8,004 
Depression 12.4 (498) 14.9 (299) 14.6 (176) 17.8 (142) 13.9 
(1,115) 
8,012 
 Medication for 
depression 
 
6.7 (267) 7.7 (155) 8.1 (97) 11.2 (89) 7.6 (608) 8,004 
DM2 5.8 (233) 5.1 (102) 6.3 (76) 6.8 (54) 5.8 (465) 8,018 
 Medication for DM2 5.8 (231) 4.7 (94) 6.2 (74) 6.8 (54) 5.7 (453) 7,964 
Hypercholesterolemia 20.3 (810) 20.5 (409) 20.7 (247) 23.0 (183) 20.7 
(1,649) 
7,985 
 Medication for 
hypercholesterolemia 
 
15.0 (600) 14.3 (286) 15.6 (187) 16.7 (133) 15.1 
(1,206) 
7,995 
Arterial hypertension 24.5 (985) 25.0 (502) 24.8 (299) 29.1 (232) 25.1 
(2,018) 
8,032 
 Medication for HA 21.0 (842) 21.3 (427) 21.5 (258) 24.5 (196) 21.5 
(1,723) 
8,022 
1: Not all eligible participants answered to all outcomes 
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Table 4 Prevalence for risk factors of public health and socio-demographic factors by amount of mobile phone 
use 
 Prevalence, % (N)  
 
 
Lowest 
49% 
 
 
50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
Total Participants1, N 
Alcohol use2 4.6 (127) 3.8 (52) 4.8 (37) 4.7 (23) 4.4 (239) 5,389 
BMI <25 kg/m2 46.8 
(1,887) 
45.5 (916) 41.4 (501) 34.3 (275) 44.4 
(3,579) 
8,063 
 BMI 25–29 kg/m2 37.0 
(1,493) 
35.1 (707) 37.2 (450) 39.7 (318) 36.8 
(2,968) 
8,063 
 BMI≥30 kg/m2 16.3 (656) 19.5 (392) 21.4 (259) 26.1 (209) 18.8 
(1,516) 
8,063 
Physical activity3 35.6 
(1,381) 
34.4 (662) 38.4 (441) 38.7 (295) 36.0 
(2,779) 
7,711 
Non-smoker 51.1 
(1,694) 
48.0 (806) 48.6 (487) 43.9 (289) 49.2 
(3,276) 
6,653 
Smoking: < 10 packyears 19.2 (592) 24.3 (379) 19.6 (176) 23.5 (141) 21.0 
(1,288) 
6,140 
 10–20 packyears 9.3 (287) 7.6 (119) 10.6 (95) 12.3 (74) 9.4 (575) 6,140 
 >20 packyears 13.1 (405) 12.5 (194) 12.3 (111) 12.8 (77) 12.8 (787) 6,140 
 Ex-smoker 32.5 
(1,078) 
36.3 (609) 33.4 (335) 36.0 (237) 34.0 
(2,259) 
6,653 
 Current smoker 16.4 (542) 15.7 (263) 18.1 (181) 20.1 (132) 16.8 
(1,118) 
6,653 
Education: Basic 17.1 (690) 18.3 (369) 19.9 (241) 22.1 (178) 18.3 
(1,478) 
8,076 
 Secondary 28.7 
(1,158) 
25.8 (522) 29.0 (352) 28.7 (231) 28.0 
(2,263) 
8,076 
 University 54.2 
(2,188) 
55.9 
(1,131) 
51.1 (620) 49.2 (396) 53.7 
(4,335) 
8,076 
Employed 59.2 
(2,380) 
56.9 
(1,143) 
53.0 (637) 53.0 (422) 57.1 
(4,582) 
8,027 
Occupation: Labourer 38.5 
(1,546) 
37.5 (750) 38.6 (461) 37.7 (300) 38.2 
(3,057) 
8,005 
 Clerical 19.6 (787) 19.3 (386) 15.9 (190) 15.45 
(123) 
18.6 
(1,486) 
8,005 
 Managerial 21.9 (880) 20.5 (409) 19.6 (234) 17.5 (139) 20.8 
(1,662) 
8,005 
 Entrepreneur 10.2 (408) 14.8 (296) 18.7 (223) 22.7 (181) 13.8 
(1,108) 
8,005 
Relationship 81.0 
(3,269) 
80.2 
(1,620) 
73.3 (891) 70.6 (571) 78.6 
(6,351) 
8,081 
1: Not all eligible participants answered to all outcomes 
2: Risk drinking (yes/no) according to Finnish guidelines 
3: Daily light/heavy physical activity at work/leisure 
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Table 5 Odds ratio, confidence intervals, p trend and prevalence for diagnoses and medications by amount of 
mobile phone use 
 OR1 (95% CI)  
 Lowest 49% 50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
P trend 
Angina pectoris/MI 1 (reference)  1.35 (0.98–
1.86)  
1.31 (0.89–
1.93) 
1.79 (1.17–
2.75) 
0.01 
Asthma 1 (reference) 1.48 (1.09–
2.00) 
1.85 (1.33–
2.58) 
1.70 (1.15–
2.52) 
0.00 
Cancer 1 (reference) 1.09 (0.86–
1.37) 
1.06 (0.80–
1.40) 
1.23 (0.90–
1.86) 
0.23 
COPD 1 (reference) 1.32 (0.81–
2.16) 
1.26 (0.70–
2.26) 
0.86 (0.38–
1.94) 
0.82 
Depression 1 (reference) 1.14 (0.97–
1.33) 
1.13 (0.93–
1.36) 
1.43 (1.16–
1.76) 
0.00 
 Medication for depression 1 (reference) 1.11 (0.90–
1.36) 
1.18 (0.92–
1.50) 
1.68 (1.30–
2.17) 
0.00 
DM2 1 (reference) 0.90 (0.70–
1.14) 
1.11 (0.84–
1.46) 
1.29 (0.94–
1.77) 
0.14 
 Medication for DM2 1 (reference) 0.83 (0.64–
1.07) 
1.10 (0.83–
1.44) 
1.29 (0.94–
1.77) 
0.17 
Hypercholesterolemia 1 (reference) 1.01 (0.87–
1.16) 
0.99 (0.83–
1.17) 
1.21 (1.00–
1.47) 
0.18 
 Medication for 
hypercholesterolemia 
 
1 (reference) 0.96 (0.82–
1.13) 
1.03 (0.85–
1.25) 
1.24 (0.99–
1.55) 
0.13 
Arterial hypertension 1 (reference) 1.02 (0.89–
1.17) 
0.97 (0.82–
1.14) 
1.31 (1.09–
1.58) 
0.05 
 Medication for HA 1 (reference) 1.02 (0.88–
1.18) 
0.99 (0.83–
1.17) 
1.29 (1.06–
1.57) 
0.07 
1: Adjusted for gender, age group 
In bold: statistically significant results 
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Table 6 Odds ratio, confidence intervals, p trend and prevalence for risk factors of public health and socio-
demographic factors by amount of mobile phone use 
 OR1 (95% CI)  
 Lowest 49% 50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
P 
trend 
Alcohol use2 1 (reference) 0.91 (0.65–1.27) 1.13 (0.77–1.65) 1.09 (0.69–1.73) 0.60 
Overweight/Obese 1 (reference) 1.13 (1.02–1.25) 1.28 (1.13–1.45) 1.72 (1.49–1.99) 0.00 
Physical activity3 1 (reference) 1.01 (0.90–1.14) 1.20 (1.05–1.38) 1.18 (1.01–1.39) 0.01 
Smoking      
 >10 packyears 1 (reference) 1.16 (1.03–1.31) 1.10 (0.95–1.27) 1.31 (1.11–1.55) 0.00 
 Ex/Current smoker 1 (reference) 1.17 (1.05–1.31) 1.21 (1.05–1.38) 1.39 (1.19–1.63) 0.00 
Education: 
Secondary/University 
 
1 (reference) 0.97 (0.87–1.07) 0.82 (0.72–0.92) 0.73 (0.63–0.85) 0.00 
Employed 1 (reference) 0.85 (0.73–0.98) 0.71 (0.60–0.84) 0.60 (0.49–0.73) 0.00 
Occupation4      
 Labourer 1 (reference) 1.10 (0.88–1.37) 1.14 (0.87–1.50) 1.23 (0.88–1.71) 0.13 
 Clerical 1 (reference) 1.02 (0.80–1.29) 0.83 (0.61–1.12) 0.90 (0.62–1.30) 0.30 
 Managerial 1 (reference) 1.08 (0.85–1.37) 1.02 (0.76–1.37) 1.05 (0.73–1.50) 0.74 
 Entrepreneur 1 (reference) 1.83 (1.42–2.37) 2.28 (1.68–3.10) 3.06 (2.13–4.40) 0.00 
Relationship 1 (reference) 0.99 (0.86–1.13) 0.66 (0.57–0.77) 0.57 (0.48–0.68) 0.00 
1: Adjusted for gender, age group 
2: Risk drinking (yes/no) according to Finnish guidelines 
3: Daily light/heavy physical activity at work/leisure 
4: Other/Outside work as a base outcome 
In bold: statistically significant results 
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Table 7 Odds ratio, confidence intervals, p trend and prevalence for diagnoses and medications by amount of 
network adjusted mobile phone use 
 OR1 (95% CI)  
 Lowest 49% 50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
P trend 
Angina pectoris/MI 1 (reference)  1.09 (0.79–
1.51)  
1.24 (0.85–
1.81) 
1.39 (0.90–
2.13) 
0.09 
Asthma 1 (reference) 1.29 (0.95–
1.75) 
1.63 (1.16–
2.28) 
1.73 (1.18–
2.53) 
0.00 
Cancer 1 (reference) 0.77 (0.61–
0.98) 
0.86 (0.66–
1.14) 
0.94 (0.69–
1.29) 
0.36 
COPD 1 (reference) 1.32 (0.81–
2.16) 
1.26 (0.70–
2.26) 
0.86 (0.38–
1.94) 
0.82 
Depression 1 (reference) 0.88 (0.74–
1.03) 
1.10 (0.91–
1.32) 
1.17 (0.95–
1.45) 
0.14 
 Medication for depression 1 (reference) 1.01 (0.82–
1.24) 
1.00 (0.78–
1.28) 
1.23 (0.93–
1.61) 
0.27 
DM2 1 (reference) 0.90 (0.71–
1.15) 
0.87 (0.65–
1.16) 
1.33 (0.98–
1.80) 
0.37 
 Medication for DM2 1 (reference) 0.83 (0.64–
1.06) 
0.83 (0.61–
1.11) 
1.31 (0.97–
1.76) 
0.55 
Hypercholesterolemia 1 (reference) 1.01 (0.87–
1.16) 
0.89 (0.75–
1.06) 
1.05 (0.86–
1.27) 
0.79 
 Medication for 
hypercholesterolemia 
 
1 (reference) 0.99 (0.85–
1.17) 
0.85 (0.70–
1.03) 
1.17 (0.94–
1.44) 
0.84 
Arterial hypertension 1 (reference) 0.95 (0.83–
1.09) 
0.92 (0.78–
1.07) 
1.06 (0.89–
1.28) 
0.94 
 Medication for HA 1 (reference) 0.88 (0.77–
1.02) 
0.85 (0.71–
1.01) 
1.03 (0.85–
1.25) 
0.07 
1: Adjusted for gender, age group 
In bold: statistically significant results 
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Table 8 Odds ratio, confidence intervals, p trend and prevalence for risk factors of public health and socio-
demographic factors by amount of network adjusted mobile phone use 
 OR1 (95% CI)  
 Lowest 49% 50–74th 
percentile 
75–89th 
percentile 
90-100th 
percentile 
P trend 
Alcohol use2 1 (reference) 0.86 (0.63–
1.19) 
0.91 (0.61–
1.36) 
0.76 (0.46–
1.26) 
0.26 
Overweight/Obese 1 (reference) 0.98 (0.88–
1.08) 
0.99 (0.87–
1.12) 
1.46 (1.26–
1.68) 
0.00 
Physical activity3 1 (reference) 1.08 (0.96–
1.21) 
1.28 (1.12–
1.47) 
1.32 (1.13–
1.55) 
0.00 
Smoking      
 >10 packyears 1 (reference) 0.93 (0.83–
1.05) 
0.92 (0.80–
1.07) 
1.11 (0.94–
1.31) 
0.81 
 Ex/Current smoker 1 (reference) 0.94 (0.84–
1.05) 
1.02 (0.89–
1.17) 
1.13 (0.96–
1.32) 
0.26 
Education: 
Secondary/University 
 
1 (reference) 0.88 (0.79–
0.98) 
0.79 (0.70–
0.90) 
0.67 (0.58–
0.78) 
0.00 
Employed 1 (reference) 0.93 (0.80–
1.07) 
0.81 (0.69–
0.97) 
0.62 (0.51–
0.75) 
0.00 
Occupation4      
 Labourer 1 (reference) 1.09 (0.88–
1.35) 
1.17 (0.89–
1.53) 
1.17 (0.84–
1.62) 
0.19 
 Clerical 1 (reference) 0.93 (0.73–
1.18) 
0.96 (0.72–
1.30) 
0.84 (0.58–
1.20) 
0.38 
 Managerial 1 (reference) 0.90 (0.72–
1.14) 
0.79 (0.58–
1.07) 
0.91 (0.63–
1.30) 
0.20 
 Entrepreneur 1 (reference) 1.45 (1.13–
1.87) 
1.91 (1.40–
2.60) 
2.24 (1.56–
3.22) 
0.00 
Relationship 1 (reference) 1.08 (0.94–
1.23) 
0.83 (0.70–
0.96) 
0.61 (0.51–
0.73) 
0.00 
1: Adjusted for gender, age group 
2: Risk drinking (yes/no) according to Finnish guidelines 
3: Daily light/heavy physical activity at work/leisure 
4: Other/Outside work as a base outcome 
In bold: statistically significant results 
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Figure 3 SF-12 Physical Health Composite Score and call-time categories 
  
 
Figure 4 SF-12 Mental Health Composite Scores and call-time categories 
 
 
Additional analysis with the hands-free coefficient removed from the exposure assessment 
showed no considerable changes in the results. 93.5% of the participants had the hands-free 
coefficient 1 or 0.95.   
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4 DISCUSSION 
 
 
 
4.1 Main results 
 
The results show several differences in health-related characteristics in relation to the amount 
of call-time in the Finnish Cosmos study. The participants in the highest decile of weekly call-
time had higher prevalence of angina pectoris, asthma, depression and arterial hypertension at 
the baseline. Similar findings for medications for depression and arterial hypertension 
supported these results. Prevalence of overweight, smoking and daily physical activity 
increased with call-time. High amount of call-time was more common among participants with 
lower education and employment and with those who were entrepreneurs and single.  
Most of the associations with the diseases and medications were not observed when the 
exposure variable was adjusted for the network used. Thus, the findings ignoring network type 
had more to do with the call-time itself than the network used. Associations with asthma, socio-
demographic factors and physical activity were similar in the network analysis than in the 
original analysis. In addition, prior history of cancer was not associated with call-time adjusted 
for network. 
In the additional analysis with the hands-free coefficient removed, the results remained similar 
compared to the original analysis. This was expected because the adjusted exposure was closely 
correlated with the original exposure. 
 
4.2 Strengths and weaknesses 
 
The main advantages of this study are the large sample size and the objective exposure 
assessment. A large sample of participants increased statistical power and precision of the 
analysis. Selection bias was minimized, because all participants passed the same recruitment 
process. A dropout analysis did not show major differences in outcomes between those 
included in those excluded, except in education and employment. The participation proportion 
was low among the invited, which may cause unrepresentativeness of the Finnish population. 
Furthermore, employer-owned subscriptions were excluded from the study population, which 
25 
 
may explain the high proportions of unemployed, retirees and entrepreneurs in the study. 
Nevertheless, the study analyses were based on internal comparisons among participants. This 
approach eliminates any potential selection bias caused by the exclusions and non-
participation. 
The major factors affecting the rate of RF-EMF exposure from mobile phones are call-time, 
the power of a device and the distance from a device. Call-time and network used was obtained 
from the operators, which eliminated the recall bias. In addition, it was possible to analyse the 
exposure gradient with such an exact exposure assessment. However, information of hands-
free use and other people using the phone was self-reported and cannot be regarded as 
objective. Hands-free devices decrease the exposure to the head due to the distance. Network 
affects to the power needed to connect to a base station. Not all the relevant factors affecting 
the exposure were considered in this study. The power of a device is determined by the 
properties of the device, such as the model of the mobile phone, and the power needed the 
connect to a base station. The weaker the connection, the more power is needed. In addition to 
the type of network, location affects to connection to the base station. At present, adaptive 
power control (APC) monitors signal quality and may reduce the emitted power of a mobile 
phone so that the lowest power required for maintaining a proper connection is used. (1-3,56)  
An exposure-based cross-sectional study design made it possible to analyse several risk factors 
and diseases. The major NCD and health risks are potential confounding factors in 
epidemiological studies, including studies of mobile phone use. The global burden of diseases 
is shifting from infectious diseases towards NCD (61), which include cardiovascular diseases, 
type 2 diabetes, chronic respiratory conditions and cancers. Four major risk factors are linked 
to these diseases: smoking, physical inactivity, alcohol drinking and unhealthy diets. Most of 
these risk factors were considered. Depression is also one of the leading causes of a disability 
pension in Finland (62) and is linked to decreased overall health. (63) Socio-demographic 
factors still affect the prevalence of NCD and lifestyle choices. (64)  This study evaluated many 
of these risk factors. 
In this study, it was possible to access most of the important risk factors of public health. 
Nevertheless, one major risk factor for NCD was not considered, the diet. The most commonly 
used method for evaluating diet, food frequency questionnaire, is prone to bias and 
misclassification, and its use is questionable (65). Uncertainty of self-reported data associates 
also with assessment of physical activity and BMI (66). Other methods, such as activity 
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trackers or measuring weight with a scale, would be resource-intensive, and more importantly, 
they would lower the participation rate. The amount of call-time correlated with prevalence of 
smoking and overweight, suggesting that amount of call-time is associated with an unhealthy 
lifestyle. The direction of causation is unknown, people in poor health may also need to use 
mobile phones more often. Level of physical activity may be overestimated among the 
participants, whereas weight is probably underestimated. However, this should not affect the 
comparisons between-groups within the study, as long as the estimation errors are similar 
across the groups. 
In addition, the diagnoses and medications could have been checked from national health care 
registries or from the medicine reimbursement statistics of the Social Insurance Institution of 
Finland, which would have made the study more accurate. However, many of NCD are 
diagnosed in the primary healthcare system, from which the registries are not complete. Also, 
the information from the medicine reimbursement statistics is not without problems, as a given 
medication can have several indications, i.e. be used for different diseases. The prevalences of 
the diseases and lifestyle factors were for the most part comparable to the statistics of the 
Finnish Institute for Health and Welfare (67). Risk drinking, asthma and COPD had lower 
prevalence in the study population than in the general Finnish population. The prevalences of 
risk factors and diseases seemed to vary with age and gender in this study consistently with 
population studies, for example, angina pectoris was more common among older participants 
and men. 
One thing that is not considered in this study, is the changes over time in the amount of mobile 
phone use. This would affect the results if the changes were dissimilar across the categories. In 
the earlier Cosmos publication, the consistency of the amount of the weekly call-time was quite 
high when comparing the baseline data to the 4-year follow-up (54). 
The cross-sectional method is appropriate when studying confounding factors. The method 
restrains from inferring anything about the causality. However, causal relationships of the 
variables are not important, when considering the profiles of the mobile phone users at the 
baseline as the aim was to evaluate the underlying differences within the study population, not 
assess the effect of the exposure of interest. 
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4.3 Consistency with other studies 
 
In the previous Cosmos publication, the association between headache and mobile phone use 
largely disappeared after adjustment for confounders. (54) This reinforces the results of this 
study.  
Few studies have been conducted with mobile phone use and NCD and common risk factors. 
Previous studies have suggested that mobile phone use is related to lower physical activity, 
higher BMI, as well as more common smoking and alcohol use, but these studies have mainly 
covered adolescents. (68-70) In this study, the highest 25 per cent of the participants with the 
largest amount of weekly call-time had increased physical activity. The discordant findings 
might be due to the nature of confounding: the common risk factors and diseases might affect 
the mobile phone use and the outcomes in some studies, but the confounding factors are not 
necessarily generalizable. 
The findings on depression and angina pectoris were similar to previous studies. (7,44)  No 
previous epidemiological studies were found in the literature on asthma and hypertension in 
relation to mobile phone use.   
Mobile phones have been associated with intracranial neoplasms in some studies. (46) Here, 
the association between call-time and prior history of cancer was not strong. Previous studies 
have been focusing on studying the potential causal relationships between mobile phone use 
and tumours, whereas here the focus was on diagnoses preceding the exposure. Additionally, 
there are no known risk factors for brain tumours, with the exception of ionizing radiation, 
allergies and genetic factors. (71-73) Lifestyle factors studied here do not explain the previous 
findings on intracranial tumours and mobile phone use. 
 
4.4 Conclusion 
 
Participants with larger amount of call-time had increased prevalence of NCD and major NCD 
risk factors. This may indicate a need for adjustment for other risk factors, or if not controlled 
for, source of bias in future mobile phone studies, especially Cosmos studies with the same 
data.  
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In the future studies, a focus should be on the long-term effects of mobile phone use with a 
cohort design. Adverse health effects of RF-EMF exposure still require careful consideration.  
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